Metabolomics Market Size, Share and Growth Demand Forecast 2031

New York, United States, Mon, 31 Jul 2023 06:01:59 / Comserve Inc. / -- The global metabolomics market is anticipated to grow with a CAGR of 13% over the forecast period, i.e., 2022-2031.

Research Nester published a report titled “Metabolomics Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the metabolomics market in terms of market segmentation by product & services, application, indication, metabolomics, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global metabolomics market is anticipated to grow with a CAGR of 13% over the forecast period, i.e., 2022-2031. The market is segmented by indication into cancer, cardiovascular disorders, and neurological disorders, out of which, the cancer segment is projected to display the largest revenue of ~USD 580 Billion by the end of 2031. Moreover, in the year 2021, the segment generated a revenue of ~USD 260 Billion.

The global metabolomics market is estimated to garner a revenue of USD 5 Billion by the end of 2031, up from a revenue of USD 2 Billion in the year 2021. Increasing adoption of metabolomics in precision medicine, along with advancements in technological instruments and increased installation of diagnostics devices are some of the major factors anticipated to drive the growth of the market during the forecast period.

Geographically, the global metabolomics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in the Asia Pacific region is anticipated to garner significant revenue on the back of increasing biotech ground-breaking work and pharmaceutical utilization is prompting constant innovation, thereby enhancing development for metabolomics in the worldwide market. More than USD 8 million was issued by the government of Japan by UNICEF East Asia and Pacific Regional Office to support digital immunization tools in Cambodia, Lao PDR, Mongolia, the Philippines, Timor-Leste, and Vietnam.

Request Report Sample@ https://www.researchnester.com/sample-request-515

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook, etc. has also been covered and displayed in the research report.

Increasing Adoption of Metabolomics in Chronic Diseases to Drive the Market Growth

As per the Centers for Disease Control, 90% of USD 3.8 trillion, total nation’s healthcare costs are attributed to people with chronic diseases and mental health disorders. In the U.S, in 2018, 51.8% of adults had at least one chronic condition while 27.2% had multiple chronic conditions.

Chronic conditions such as arthritis, cancer, chronic obstructive pulmonary disease (COPD), coronary heart disease, asthma, diabetes, hypertension, stroke, and kidney failure are the most prevalent diseases that affect more people across the world. The presence of multiple chronic conditions decreases the quality of life, and increases healthcare costs, and mortality rate. Here metabolomics plays a key role to diagnose and understanding the phenotype and mechanism of disorder to customizing prescriptions based on a single individual.

However, the complexity increase in interpreting data, the high price of metabolomic instruments, and the scarcity of professionals are expected to operate as a key restraint to the growth of the metabolomics market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global metabolomics market which includes company profiling of Agilent Technologies, Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker, Danaher, Human Metabolome Technologies America Inc., LECO Corporation, Metabolon, Inc., Shimadzu Corporation. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global metabolomics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Purchase Copy of this Report@ https://www.researchnester.com/purchage/purchase_product.php?token=515

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

For more information, please contact:

Research Nester
Email: [email protected]
Tel: +1 646 586 9123

The post Metabolomics Market Size, Share and Growth Demand Forecast 2031 appeared first on Comserveonline.